Propranolol for primary and secondary propylaxis of variceal bleeding in children with cirrhosis

Turkish Journal of Pediatrics

Volumn 42, Issue 1, 2000, Pages 31-33

  Özsoylu, Şinasi ^a   Koçak, Nurten ^b   Demir, Hülya ^b   Yüce, Aysel ^b   Gürakan, Figen ^b   Özen, Hasan ^b  

^a FATIH UNIVERSITY   (Turkey)

^b HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Children; Cirrhosis; Prophylaxis; Propranolol; Variceal bleeding

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; PROPRANOLOL; VITAMIN K GROUP;

ADOLESCENT; ADULT; ARTICLE; BLEEDING; CHILD; CONTROLLED STUDY; DRUG EFFICACY; ESOPHAGUS VARICES; ESOPHAGUS VARICES BLEEDING; HUMAN; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; PORTAL HYPERTENSION; TREATMENT OUTCOME;

ADOLESCENT; ADRENERGIC BETA-ANTAGONISTS; CHILD; CHILD, PRESCHOOL; GASTROINTESTINAL HEMORRHAGE; HUMANS; HYPERTENSION, PORTAL; LIVER CIRRHOSIS; PROPRANOLOL; RETROSPECTIVE STUDIES;

EID: 1642633613     PISSN: 00414301     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Garcia-Pagán JC, Bosch J. Pharmacological prevention of variceal bleeding. New developments. Baillière's Clin Gastroenterol 1997; 11: 271-287.
2. Lebrec D, Poynard T, Hillon P, Benhamou JP. Propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis. N Engl J Med 1981; 305: 1371-1374.
3. Burroughs AK, Jenkins WJ, Sherlock S, et al. Controlled trial of propranolol for the prevention of recurrent variceal hemorrhage in patients with cirrhosis. N Engl J Med 1983; 309: 1539-1541.
4. Özsoylu S, Koçak N, Yüce A. Propranolol therapy for portal hypertension in children. J Pediatr 1985; 106: 317-321.
5. Conn HO, Grace ND, Bosch J, et al. Propranolol in the prevention of the first hemorrhage from esophagogastric varices: a multicenter, randomised clinical trial. Hepatology 1991; 13: 902-912.
6. The Italian Multicenter Projector for Propranolol in Prevention of Bleeding. Propranolol for prophylaxis of bleeding in cirrhotic patients with large varices: a multicenter, randomised clinical trial. Hepatology 1988; 8: 1-5.
7. Pascal JP, Cales P, Multicenter Study Grop. Propranolol in the prevention of first upper gastrointestinal tract hemorrhage in patients with cirrhosis of the liver and esophageal varices. N Engl J Med 1987; 317: 856-861.
8. Villeneuve JP, Pornier-Layrargues G, Infante-Rivard C, et al. Propranolol for the prevention of recurrent variceal hemorrhage, a controlled trial. Hepatology 1986; 6: 1239-1243.
9. Pugh RN, Murray-Lyon IM, Dawson JL, et al. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973; 60: 646-649.
10. Garcia-Tsao G, Grace ND, Groszmann RJ, et al. Short-term effects of propranolol on portal venous pressure. Hepatology 1986; 6: 101-106.
11. Feu F, Garcia-Pagán JC, Bosch J, et al. Relation between portal pressure response to pharmacotherapy and risk of recurrent variceal hemorrhage in patients with cirrhosis. Lancet 1995; 346: 1056-1059.
12. Poynard T, Glase P, Pasta L, et al. Beta-adrenergic-antagonist drugs in the prevention of gastrointestinal bleeding in patients with cirrhosis and esophageal varices: an analysis of data and prognostic factors in 589 patients from four randomized clinical trials. N Engl J Med 1991; 324: 1532-1538.
13. D'Amico G, Pagliaro L, Bosch J. The treatment of portal hypertension: a metaanalytic review. Hepatology 1995; 22: 332-354.
14. Lin HC, Soubrane O, Cailmail S, Lebrec D. Early chronic administration of propranolol reduces the severity of portal hypertension and portal-systemic shunts in conscious portal vein stenosed rats. J Hepatol 1991; 13: 213-219.
15. Escorsell A, Ferayorni L, Bosch J, et al. The portal pressure response to â-blockade is greater in cirrhotic patients without varices than in those with varices. Gastroenterology 1997; 112: 2012-2016.
16. Alvarez F. Long-term treatment fo bleeding caused by portal hypertension in children. J Pediatr 1997; 131: 798-800.